Literature DB >> 22834143

[Enhancing the immunogenic activity of influvac vaccine in the use of adjuvant TI complexes modified by echinochrome A].

A V Tsybul'skiĭ, A M Popov, A A Artiukov, A N Mazeĭka, É Ia Kostetskiĭ, N M Sanina, O N Krivoshapko.   

Abstract

The self-assembly of marine macrophyte glycolipids, holothurian saponin, and cholesterol gave rise to nanoscale morphological structures called tubular immunostimulating (TI) complexes. Whether the latter could be used on the basis of vaccine preparations containing the influenza virus subunit antigens was studied. There was an obvious increase in the immunogenicity of influenza virus hemagglutinin when the experimental animals were immunized with this antigen as part of TI complexes. It was shown that the adjuvant activity of the TI complex to influenza virus hemagglutinin could be enhanced by adding the known antioxidant echinochrome A from a sand-dollar (Echinarachnius parma) to the matrix of the TI complex.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22834143

Source DB:  PubMed          Journal:  Vopr Virusol        ISSN: 0507-4088


  3 in total

1.  Amelioration of endotoxin-induced uveitis treated with the sea urchin pigment echinochrome in rats.

Authors:  Anton Lennikov; Nobuyoshi Kitaichi; Kousuke Noda; Kazuomi Mizuuchi; Ryo Ando; Zhenyu Dong; Junichi Fukuhara; Satoshi Kinoshita; Kenichi Namba; Shigeaki Ohno; Susumu Ishida
Journal:  Mol Vis       Date:  2014-02-07       Impact factor: 2.367

2.  Marine Polyhydroxynaphthoquinone, Echinochrome A: Prevention of Atherosclerotic Inflammation and Probable Molecular Targets.

Authors:  Aleksandr A Artyukov; Elena A Zelepuga; Larisa N Bogdanovich; Natalia M Lupach; Vyacheslav L Novikov; Tatyana A Rutckova; Emma P Kozlovskaya
Journal:  J Clin Med       Date:  2020-05-15       Impact factor: 4.241

Review 3.  Sea Urchin Pigments: Echinochrome A and Its Potential Implication in the Cytokine Storm Syndrome.

Authors:  Tamara Rubilar; Elena S Barbieri; Ayelén Gazquez; Marisa Avaro
Journal:  Mar Drugs       Date:  2021-05-11       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.